|
|
 |
|
Viewing report
|
|
|
|
Cross-Border M&A Activity In Pharmaceutical & Healthcare Industry - Q3 2011
GlobalData, Nov 2011, Pages: 12
Cross-Border M&A Activity In Pharmaceutical & Healthcare Industry - Q3 2011
Summary
GlobalData's “Cross-Border M&A Activity In Pharmaceutical & Healthcare Industry - Q3 2011” report is an essential source of data and trend analysis on cross border mergers and acquisitions (M&As) and asset transactions in the pharmaceuticals industry. The report provides detailed information on cross border and domestic M&As and asset transactions registered in the pharmaceuticals industry in Q3 2011. The report provides detailed comparative data on the number of deals and their value in the last five quarters segregated into domestic and cross border transactions.
Data presented in this report is derived from GlobalData’s proprietary in-house Pharmaceuticals eTrack deals database and primary and secondary research.
Scope
- Analysis of the cross border M&A trends for the pharmaceutical industry in the global arena.
- Analysis of M&As and asset transactions in the pharmaceutical industry.
- Information on the top deals happened in the pharmaceutical industry.
- Geographies covered include – North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.
Reasons to buy
- Enhance your decision making capability in a more rapid and time sensitive manner.
- Find out the major deal performing regions for investments in your industry.
- Identify companies that are aggressively looking to acquire companies in operating in your industry
- Do deals with an understanding of how competitors are involving in mergers and acquisitions that have shaped the pharmaceutical industry.
- Identify growth segments and opportunities in each region within the industry.
Keywords
Pharma, Pharmaceuticals, Healthcare, Cross Border, Domestic, Deal Value, Deal Volume, North America, Europe, Asia-Pacific, Rest of the World (ROW), Merger, M&A, Acquisition, Asset Purchase
|
|
|
|
